BlueRock Therapeutics società ha sostenuto
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
leggi di più
Great excited journey so far, look forward to many years to come, and our success is the success for a lot of patients and family.
Quali sono alcune delle cose migliori della tuo team?
Friendly and supportive, purpose driven for common good
Qual è la parte migliore del tuo compenso?
401K contribution match and HSA
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Caring, friendly, supportive and trust
Cosa ti piace di più del team di leadership?
Great transparency with clear mission and roadmap for the teams
Che cosa ti rende più felice sul posto di lavoro?
Learning, sense of urgency, and passion for the good cause.
Other Employee Reviews for BlueRock Therapeutics
×